Market Share of Cancer Biomarkers Industry
The cancer biomarkers market is highly competitive and consists of a few major players. Some of the companies which are currently dominating the market are 23andMe, Abbott Laboratories Inc., Agilent Technologies, Ambry Genetics, Biomerieux, Celera Corporation (Quest Diagnostics), F. Hoffmann-La Roche Ltd, Hologic Inc., Illumina Inc., and Thermo Fisher Scientific, among others, hold substantial shares in the market.
Cancer Biomarkers Market Leaders
Abbott Laboratories Inc.
Thermo Fisher Scientific
Biomerieux
Illumina Inc.
F. Hoffmann-La Roche Ltd
*Disclaimer: Major Players sorted in no particular order